Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient
oleh: Sha-Sha Wang, Fang Wang, Zhen Zeng, Fang Gao, Huan-Huan Liu, Hui-Na Wang, Yi Hu, Hai-Feng Qin
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2022-12-01 |
Deskripsi
Subjek
RET intergenic fusion; pralsetinib; lung adenocarcinoma; novel intergenic; tyrosine kinase inhibitors